PLK1 and ovarian cancer: Studies have shown that inhibiting PLK1 in the presence of PTX [201,216] resensitized ovarian cancer cells to PTX and reduced cell proliferation, as well as inducing apoptosis in HGSOC cells with CCNE1 amplification.